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INTRODUCTION 
 Analytical chemistry is the science that seeks ever improved means of measuring 
the chemical composition of natural and artificial materials. Chemical composition is the 
entire picture (composition) of the material at the chemical scale and includes geometric 
features such as molecular morphologies and distributions of species within a sample as 
well as single dimensional features such as percent composition and species identity.1 
 
To be effective and efficient, analyzing samples requires expertise in 
1. The chemistry that can occur in a sample. 
2. Analysis and sample handling methods for a wide variety of problems            
(the tools-of-the-trade). 
3. Accuracy and precision of the method. 
4. Proper data analysis and record keeping. 
 The major stages of an analytical process are described as follows: 
 
Steps in analytical cycle 
         The pharmaceutical analysis comprises the procedures necessary to determine the 
“identity, strength, quality and purity” of such compounds. It also includes the analysis of 
raw material and intermediates during manufacturing process of drugs. 
 
 
 
Sample 
preparation 
Sample 
analysis 
Data 
handling 
Sample 
transport and 
storage Archiving 
Report 
generation 
Information 
to customer 
Sample 
collection and 
sampling 
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Types 
Qualitative analysis 
 Qualitative inorganic analysis seeks to establish the presence of a given element 
or inorganic compound in a sample. 
 Qualitative organic analysis seeks to establish the presence of a given functional 
group or organic compound in a sample. 
Quantitative analysis2 
 Quantitative analysis seeks to establish the amount of a given element or 
compound in a sample. 
Methods of detecting analytes 
1. Physical means 
 Mass 
 Color 
 Refractive index 
 Thermal conductivity 
2. With electromagnetic radiation (Spectroscopy) 
 Absorption 
 Emission 
 Scattering 
3. By an electric charge  
 Electrochemistry  
 Mass spectrometry 
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Traditional analytical techniques
Titration 
 Titration involves the addition of a reactant to a solution being analyzed until 
some equivalence point is reached. Often the amount of material in the solution being 
analyzed may be determined.
Gravimetry3 
 Gravimetric analysis involves determining the amount of material present by 
weighing the sample before and/or after some transformation. A common example used 
in the determination of the amount of water in a hydrate by heating the sample to remove 
the water such that the difference in weight is due to the water lost.
Instrumental Analysis4 
 
 
 
 
 
Block diagram 
instrument 
stimulus and measurement of response
1. Separation Techniques
 Separation processes are used to decrease the complexity of material mixtures. 
Chromatography and electrophoresis
 
Chromatographic methods 
 Chromatography is a technique by which the components in a sample, carried by 
the liquid or gaseous phase, are resolved by sorption
phase. 
 
There are various advanced chromatographic techniques, which are most reliable 
and widely used for the estimation of multicomponent drugs in their formulation namely, 
a) Gas chromatography (GC)
b) High Performance Thin Layer Chromatography (HPTLC)
c) High Performance Li
 
 
 
 
 
 
of an analytical 
showing the 
 
 
 is representative of this field. 
-desorption steps on the stationary 
 
 
quid Chromatography (HPLC) 
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 High performance liquid chromatographic separation is based on interaction and 
differential partition of the sample between the mobile phase and stationary phase. The 
commonly used chromatographic methods can be roughly divided into the following 
groups, 
I. Chiral 
II. Ion-exchange 
III. Ion pair/affinity 
IV. Normal phase 
V. Reverse phase 
VI. Size exclusion 
 
 When compared to classical column chromatography, this technique is preferred 
because of its improved performance in terms of rapidity, specificity, sensitivity, 
accuracy, convenience, ease of automation and the cost of analysis. 
 
 Advance in column technology, high pressure pumping system and sensitive 
detectors have transformed liquid column chromatography into a high speed, efficient, 
accurate and highly resolved method of separation. 
 
2. Hybrid Techniques 
 
 Combination of the above techniques produces ‘hybrid’ or ‘hyphenated’ 
techniques. Several examples are in popular use today and new hybrid techniques are 
under development. For example 
a) GC-MS 
b) LC-MS 
c) HPLC/ ESI-MS 
d) LC-DAD 
e) CE-MS 
f) CE-UV 
3. Microscopy 
 The visualization of single molecules, single cells, biological tissues and nano- 
micro materials is very important and attractive approach in analytical science. Also, 
hybridization with other traditional analytical tools is revolutionizing analytical science. 
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Microscopy can be categorized into three different fields: optical microscopy, electron 
microscopy, and scanning probe microscopy. Recently, this field is rapidly progressing 
because of the rapid development of computer and camera industries. 
4. Lab-on-a-chip 
 Miniaturized analytical instrumentation, which is also called as micro fluidics or 
micro total analysis system (µTAS). The beauty of lab-on-a-chip system is that a whole 
device can be visualized under a microscope. 
Method of data analysis6 
a. Standard Curve 
 A standard method for analysis of concentration involves the creation of a 
calibration curve. This allows for determination of the amount of a chemical in a material 
by comparing the results of unknown sample to those of a series known standards. 
5. Internal Standard 
 Sometimes an internal standard is added at a known concentration directly to an 
analytical sample to aid in quantitation. The amount of analyte present is then determined 
relative to the internal standard as a calibrant. 
 Quality assurance plays a central role in determining the safety and efficacy of 
medicines. Highly specific and sensitive analytical technique holds the key to design, 
development, standardization and quality control of medicinal products. 
 The efficacy and safety of a medicinal product can be assured by analytical 
monitoring of its quality. It is important that analytical procedure proposed of a particular 
active ingredient or its dosage form should be systematically sound under the condition in 
which it is to be applied. 
New Drug Discovery 
 New drugs have been discovered from two major sources 
 Synthetic chemicals 
 Natural products including plants, animal and microbes. 
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 The number of drugs introduced into the market has been increasing at an 
alarming rate. Newer analytical methods are developed for these drugs or drug 
combinations because of the following reasons 
i) The drug or combination may not be official in any pharmacopoeia. 
ii) A literature search may not reveal an analytical procedure for the drug or 
its combination. 
iii) Analytical methods may not be available for the drug combination due to 
the interference caused by excipients. 
iv) Analytical methods for the quantification of drug or drug combination with 
other drugs may not be available. 
On the other hand, the existing procedure may 
 Require expensive instruments, reagents, solvents etc. 
 Involve any tedious extraction or separation steps which may be quite time 
consuming. 
 Not be rapid, reliable or sensitive. 
 The newly developed analytical methods find their importance in various 
fields such as 
  Research institutions 
 Quality control department in industries 
 Approved testing laboratories  
 Bio-pharmaceutical and bio-equivalence studies 
 Clinical pharmacokinetic studies 
 
3 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
 High performance liquid chromatography is a very sensitive analytical technique 
most widely used for quantitative and qualitative analysis of pharmaceuticals. The 
principle advantage of HPLC compared to classical column chromatography is improved 
resolution of the separated substance, faster separation times and the increased accuracy, 
precision and sensitivity8. 
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Principle of Separation and its type 
 There are four types of chromatography in which the mobile phase is a liquid. The 
mobile phase is pumped through the packed column, under high pressure.  
a. Partition chromatography 
i. Normal phase chromatography 
ii. Reverse phase chromatography 
b. Adsorption or liquid solid chromatography 
c. Ion exchange chromatography 
d. Size exclusion or gel permeation chromatography 
 
NORMAL PHASE CHROMATOGRAPHY 
 In normal phase mode, the stationary phase (e.g. silica gel) is polar in nature and 
the mobile phase is non- polar in this technique, non-polar compounds travel faster and 
are eluted first. This is because less affinity between solute and stationary phase. Polar 
compounds are retained for longer time in the column because more affinity towards 
stationary phase and takes more time to be eluted from the column. This is not 
advantageous in pharmaceutical applications since most of the drug molecules polar in 
nature and takes longer time to be eluted and detected. Hence this technique is not widely 
used in pharmacy. 
SOLUTE POLARITY:-  
 Adsorption strengths increased with increasing solute polarity and this is favorable 
interaction between the polar solutes and the polar stationary phase increases the elution 
time (note:-the interaction strength not only depends on the functional groups in the 
enlight molecule, but also stearic factors). 
Reverse phase chromatography 
 In RP-HPLC the stationary phase is non-polar often a hydrocarbon and the mobile 
phase is relatively polar such as water, methanol or Acetonitrile. In RPC the solutes are 
eluted in the order of their decreasing polarities. These are prepared by treating the 
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surface of silanol group with an organochlorosilane reagent. 
Reverse phase mode 
 Non-polar stationary phase and polar mobile phase is used here. 
Mechanism 
 Retention by interaction of the stationary phase non-polar hydrocarbon chain with 
non-polar parts and sample molecules. 
ADSORPTION OR LIQUID SOLID CHROMATOGRAPHY 
 The principle of separation is adsorption, separation of components takes place 
because of difference in affinity of compounds towards stationary phase. This principle is 
seen in normal phase as well as reverse phase mode, where adsorption will takes place . 
 
ION-EXCHANGE CHROMATOGRAPHY 
 In ion exchange chromatography, retention is based on the attraction between 
solute ions and charged sites bound to stationary phase. Ions of the same charge are 
excluded. Some types of ion Exchangers include :( 1) polystyrene resins-allows cross 
linkage which increases the stability of the chain. Higher cross linkage reduces swerving, 
which increases the equilibration time and ultimately improves selectivity. (2)Cellulose 
and dextran ion-exchangers (gels) these possess larger pore sizes and low charge densities 
making them suitable for protein separation. (3) controlled-pore glass or porous silica  
            In general, ion-exchangers favor the binding of ions of higher charge and smaller 
radius. An increase in counter ion (with respect to the functional groups in resins) 
concentration reduces the retention time. An increase in ph reduces the retention time in 
cation exchange while a decrease in ph reduces the retention time in anion exchange  
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SIZE EXCLUSION CHROMATOGRAPHY 
  Size exclusion chromatography (SEC) also known as gel permeation 
chromatography or gel filtration chromatography, separates particles on the basics of size. 
It is generally a low resolution chromatography and thus it is often reserved for the final, 
“polishing” step of purification. It is also useful for determining the tertiary structure and 
quaternary structure of purified proteins, and is the primary technique for determining the 
average molecular weight of natural and synthetic polymers  
METHODS OF QUANTITATIVE ANALYSIS: 
 The sample or solute is analyzed quantitatively in HPLC by either peak height or 
peak area measurements. Peak areas are proportional to the amount of the material eluting 
from the column as long as the solvent flows at constant rate. Peak heights are 
proportional to the amount of the material only when peak widths are constant and are 
strongly affected by the sample injection techniques. They are five principles evaluation 
methods for quantifying the solute10  
(a)Calibaration by Standards:  
 Calibration curves for each component are prepared from pure standards, using 
identical injection volumes of operating conditions for standards and samples. The 
concentration of solute is read from its curve if the curve is linear  
                                           X=K x Area 
                               Where, x=concentration.  
                                           K=proportionality constant (slope of the curve). 
In this evaluation method, only the area of the peaks of interest is measured. Relative 
response factors must be considered when converting areas to volume and when the 
response of the given detector differs for each molecular type of compounds. 
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(b)Internal Standard Method: 
 In this technique, a non quantity of internal standard is chromatographed and area 
Vs concentration is ascertained. Then a quantity of internal standard is added to the raw 
sample prior to any sample pretreatment or separation operations. The peak area of the 
standard in the sample run is compared with the peak are when the standard is run 
separately. This ratio serves as correction factor for variation in sample size, for losses in 
any preliminary pretreatment operations, or for incomplete elution of the sample. The 
material selected for the internal standard must be completely resolved from adjacent 
sample components and should not interfere with the sample components and never be 
present in samples 
                        
                      Area of sample 
                       Area ratio =    
                           Area of internal standard 
 
        Area of sample    
     Sample concentration =                                          x concentration of standard 
                                            Area of internal standard          
                     
(c)Area normalization 
 This technique is often used for the sample having identical components. It is used 
to evaluate the absolute purity of the sample. The procedure is to total up the areas under 
all peaks and then calculates the percentage of the total area that is contributed by the 
compound of interest. For this method the entire sample must be eluted, all components 
must be separated and each peak must be completely resolved  
 
(d)Standard addition method 
 If only few samples are to be chromatographed, it is possible to employ the 
method of standard edition (s).the chromatogram of the unknown is recorded, then a 
known amount of analyte (s) is added and the chromatogram is repeated using same 
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reagents, instruments and other conditions. From the increase in the peak area (or peak 
height), the original concentration can be computed by interpolation. 
      If an instrumental reading(area/height) ‘Rx’ is obtained, from a sample of unknown 
‘x’ and a reading ‘Rt’ is obtained from the sample to which a known concentration ‘a’ of 
analyte has been added, then ‘x’ can be calculated from     
                                                                                                                                                                                        
              x                     Rx      
                                               __________ =  ________      
                                                     x+a                   Rt 
A correction for dilution must be made if the amount of standard added, changes 
the total sample volume significantly. It is always advisable to check the result by adding 
at least one other standard. 
Principle of separation 
      HPLC is based on the mechanism of adsorption, partition, ion exchange or size 
exclusion, depending on the type of stationary phase used. HPLC involves a solid 
stationary phase, normally packed inside a stainless- steel column, and a liquid mobile 
phase. Separation of the components of a solution results from difference in the relative 
distribution ratios of the solutes between the two phases  
 
 The majority of the HPLC separation are done with Reversed phase separation, 
probably over 90%.In reversed phase separation organic molecules are separated based on 
the degree of hydrophobicity. There is a correlation between the degree of lipophylicity 
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and retention in the column. This is the list of mobile phase parameters effecting retention 
and separation in reversed phase .Elution order in normal phase HPLC shows that the 
polar solutes elute later then non polar lypophilic ones. 
 
HPLC EQUIPMENT 
 
 
                                 
 
 
    Schematic diagram of HPLC 
 
 
The Various parts of HPLC equipment are1 
 
1.  Reservoir - that holds the mobile phase. 
2.  Pumps - A & B to pump the mobile phase. 
3.  Sample injection - to inject the sample. 
4.  Columns - that contains the stationary phase. 
5.  Detectors - to detect the results. 
6.  Recorder – to display the results. 
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The operation has specific procedure and it depends on various factors.  
       
           They can be described as follows: 
 
1.  Reservoirs: 
 
The solvent reservoirs are glass or stainless steel containers capable of 
holding uto one liter of mobile phase. The reservoir has special caps, Teflon 
tubing and filters. 
2.  Pumps: 
 
Pumps are used to pump the solvent into the column. Most of HPLC 
work is done under pressure between about 400 to 1500 psi. 
         There are two types of pumps 
 
i) Mechanical Pumps – These pumps deliver the mobile phase at a constant flow rate. 
The mechanical pumps are  commonly  Reciprocating  Piston  types.  It consists of a 
small motor driven piston, which moves rapidly back and forth in a hydraulic chamber 
that may vary from 35-400µl in volume. On the backstroke, the separation column 
valve is closed, and the piston  pulls in solvent from the mobile phase reservoir. On the 
forward stroke, the pump pushes solvent out to the column from the reservoir. This 
type of pump system is significantly smoother because one pump is filling while the 
other is in the delivery cycle. 
  
ii)  Pneumatic Pumps –  These pumps deliver  the  mobile  phase  at  a constant 
pressure. The pneumatic pumps are commonly Gas Displacements type. It uses direct 
pressure from the  highly compressed gas to force solvent out of tube to deliver  the  
liquid  at  constant  pressure.  The  amplification  of the  original gas pressure is 
proportional to the ratio of two ends of the  piston. The pneumatic 
pumps having the advantage of pulse-less operation10-11. 
 
3. Sample Injection: - 
 
              The sample injection device is available in which sample solutions are 
injected through a self  sealing  rubber  or  Teflon disc using  micro  liter  syringe.  
Samples are injected into the HPLC via an injection port. The injection port of an 
HPLC commonly consists of an injection valve and the sample loop. The sample is 
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typically dissolved in the suitable solvent before injection into the sample loop. The 
sample is then drawn into a syringe and injected into the loop via the injection valve then 
it injects the sample into the stream of the mobile phase. Loop volumes can range 
between 10µl to 1000µl. 
 
               For syringe type and reciprocation pumps, flow in the column can be 
brought to zero and rapidly resumed by diverting the mobile phase by means of a three 
way valve placed in front of the injector. This method can be used up to very high 
pressures. 
10-11
 
 
4. Analytical Columns: - 
 
             The analytical columns are heart of HPLC system which decide efficiency 
of separation, in which actual separation are take place. There are various columns that 
are secondary to the separating column or stationary phase. 
 
I)   Guard columns 
 
              They are placed anterior to the analytical column.  They are having same 
packing material as that of analytical column but its particle size may larger. The length 
of columns are 2-10 cm, thus they dose not affect the separation. They are for 
protective purpose. They are dependable columns designed to filter or remove particles 
that clog the separation of the column.   These are used in the following cases: 
 
a. Compounds and ions that could ultimately cause “baseline drift”, decreased 
resolution, decreased sensitivity and create false peaks. 
b. Compounds that may cause precipitation upon contact with the stationary or 
mobile phase.  Compounds that might co-elute and cause extraneous peaks and 
interfere with the detection and/or quantification.10-11  
 
II) Analytical Columns 
 
          These columns are mainly involved in sample separation. They are made up of 
stainless steel  /  heavy glass / polyethylene / polyethylene ketone. These are also 
known as  micro  columns,  capillary columns  have a diameter  much  less than a 
millimeter. They allow the user to work with nanoliter sample volumes, decreased 
flow rate, and decreased solvent volume usage which may lead to cost effectiveness. 
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          The stainless steel columns are commonly used because they can give good 
separation  with  high pressure. The columns are long narrow and the length varies 
from 8 to 10 cm and 20 to 30 cm. them having the internal diameter 2 to 5 mm. The 
silica gel is most frequently used for column packing. For partition chromatography  it 
is bonded with some alkyl groups with the chain lengths of 1, 2, 8 or 18 carbons, 
cyanopropyl groups, phenyl groups and ion exchange10-11. 
  
5. Detectors 
 
The function of the detector in HPLC is to monitor the mobile phase as it 
emerges from the column. 
Different types of detectors can be used with HPLC. 
 
  Ultra-Violet (UV) Detectors: 
 
The mechanism of these detectors is based upon the light absorption 
characteristics of the sample. They measure the ability of samples to absorb light. This 
can be done at single or variable wavelengths: 
Fixed wavelength:  Measures at single wavelength. 
 
Variable wavelength: Measures one wavelength at a time, but can detect over a wide 
range of wavelengths. 
 Photodiode Array Detector: 
 
          These detectors can scan the entire UV spectrum repeatedly during the elution 
of a peak to determine if more than one substance is coeluting. 
  Fluorescence Detector: 
 
          These detectors are used for those compounds that fluoresces naturally or it can 
be made to do so by derivatization. 
  Differential Refractometer Detector: 
           It is capable of measuring refractive index changes from 10-4  to 10-5  RI 
units. They measure the ability sample molecules to bend or refract light. This property 
is called refractive index. Detection occurs when light is bent due to samples eluting 
from the column and this is read as a disparity between the two channels. 
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  Radio Chemical Detectors: 
 
           Involves use of radio labeled material usually tritium (3H) or carbon-14 (14C). It 
operates by detection of fluorescence along with beta-particle ionization.  
Electrochemical Detectors: 
Used in analysis of compounds that undergoes oxidation or reduction reactions. 
They measure the difference in electrical potential when the sample passes between the 
electrodes. It includes amperometry, coulometry, polarography, photoconductivity 
principles.10-11  
7.  Recorder 
  
         Recorders  are  used  to  record  the  responses  obtained  from  detector  after 
amplification.  They record the base line and all the peaks obtained with respect to 
time10-11 
 
ANALYTICAL METHOD DEVELOPMENT12-13 
Selecting an accurate assay procedure for each ingredient present in pharmaceutical 
dosage forms, either individually or complex dosage formulation containing several 
therapeutically and chemically compatible drugs with very similar chemical nature is a 
monumental undertaking. 
 
Separation, identification and estimation of each ingredient in such complex 
formulation are a challenging task.  The presence of excipients, additives and 
decomposition products further complicates the analysis. Therefore analytical 
development is done for new drug where no methods are available. Or, alternate method 
development for existing (non pharmacopoeia) products to reduce cost and time of 
analysis. 
 
There are different kinds of reasons for developing new methods for analysis: - 
 
• There is no any suitable method for a particular compound or 
combination of that compound. 
• The existing method may be too error, contamination-prone or may be 
not well suitable. 
• The existing method may be too expensive, time consuming or may not 
be easily automated. 
• The existing method may be having less accuracy or precision. 
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• The existing method may not provide adequate sensitivity or analyte 
selectivity in the sample. 
• There may be need of alternative method to confirm a legal or                                      
scientific reasons, analytical data originally or turned by existing method. 
 
STEPS TO BE FOLLOWED IN METHOD DEVELOPMENT 
Method development9 starts with the documentation of the developed studies. All 
data related to these studies must be established and they must be recorded in laboratory 
notebook or an electronic data base. 
 
 
1. Standard Analyte Characterization:- 
 Collection of information about the analyte or drug should be collected 
starting from the structure, physical, chemical properties toxicity, purity, 
hygroscopic nature, solubility and stability. 
 Reference standard for the sample should be obtained. In case of multiple 
components for the analysis to be analyzed in the sample, number of 
components should be noted, data is assembled and the availability of 
standards for each one is determined. 
 Proper storage are set for the reference standards (refrigerators, dessicator, 
freezer). 
 A suitable method for the sample is considered. 
 
2. Method Requirements:- 
 
The aim or requirement of the analytical method that need to be developed all 
considered and the analytical figures of merit are defined. The required detection limits, 
selectivity, linearity, range, accuracy and precision are defined. 
 
3. Literature Search and prior Methodology:- 
 
The literature for all types of information related to the analyte surveyed. 
Literature is done for synthesis, physical, chemical properties, solubility and related 
analytical method. Information can be obtained from official standard books such as 
USP/NF, AOAC standard books, periodicals, chemical manufacturers along with 
chemical abstract services and computer data banks. 
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4. Choosing of Method:- 
 
 Adaptation is more efficient than “reinventing the wheel”. If any of the 
reported methods from the literature are adaptable to the current 
laboratory setting and future needs, it is determined. 
 From the various source a methodology is adopted. The methods are 
modified. 
 If there are no reported details for the drug or the chemical then the 
drugs are investigated and are worked out. 
 
 
5. Instrumental Setup and Initial Studies:- 
 
 By using the data made for the analyte a suitable instrument method is 
selected. The instrument is set up by using standard operation 
procedure.  
 Analyte reference standard is prepared in suitable concentration by 
using various combination of solvent system. It is important to start 
with reference standard substance rather then complex sample 
components. 
 The analysis is made for the various conditions described in the 
existing literature. 
6. Optimization: 
During optimization one parameter is changed at a time, and set of conditions are 
isolated, rather than using a trial and error approach. Work has been done from an 
organized methodological plan, and every step is documented (in a lab note book) in case 
of dead ends. 
 
7. Documentation of analytical figures: 
 
 The originally determined analytical figures of merit, Limit of quantitation [LOQ] 
and Limit of the detection [LOD],  linearity, time per analysis cost, sample preparation 
etc are documented. 
 
 
 
Chapter-1                                                                                                     INTRODUCTION                                       
 
RVS College of Pharmacetical Sciences  Page 19 
 
8. Evaluation of Method Development with actual Sample: 
The sample solution should lead to unequivocal, absolute identification of the 
analyte peak of interest apart from all the other matrix components. 
 
9. Determination of Percent Recovery of Actual Sample and Demonstration of      
Quantitative Sample Analysis: 
Percent recovery for the standard analyte into a sample matrix that is shown to 
contain no analyte is determined. Reproducibility of recovery from sample to sample and 
whether the recovery has been optimized has been shown. It is not necessary to obtain 
100% recovery as long as the results are reproducible and known with high degree 
certainty. 
The validity of analytical method can be verified only by laboratory studies. 
Therefore documentation of the successful completion of the studies is the basic 
requirement for determining whether a method is suitable for its intended applications. 
 
Validation is an approach to form a basis for written procedures for production 
and process control which are designed to assure that the drug products have the identity 
strength, quality, and purity they purport or are represented to possess. 
 
Analytical Method Validation 
           
 
Definitions of validation: 
 
World health organization (WHO):  
Action of providing that any procedure, process, equipment, material activity, or 
system actually reads to the expected results.  
Food and drug administration (FDA US):  
Establishing documentation evidence, which provides a high degree of assurance 
that specific process, will consistently produce a product meeting its predetermined 
specification and quality attributes. 
European committee(EC):  
Action of providing in accordance with the principle of good manufacturing 
practice, that any procedure process equipment material, activity or system actually read 
to the expected result. 
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Types of validation:14 
Prospective Validation:  
At least three successive production size (US Via) batches, all batches made tested 
and report approved before distribution facilities and equipment qualified. 
Concurrent Validation:  
Generation of validation data concurrent or simultaneously with normal 
production schedules used in exceptional cases (low volume products); interim reports 
required. 
Retrospective Validation: 
 This is establishing documented evidence that the process is performed 
satisfactorily and consistently over time, based on review and analysis of historical data. 
The source of such data is production and QA/QC records. The issues to be addressed 
here are charged to equipment, process, specification and other relevant changes in the 
past. 
Purpose of Validation 
 
              The principal purpose of analytical method validation is to ensure that test  
methods, which are used for assessing compliance of pharmaceutical products with 
established specifications, will give accurate, reliable and reproducible results. 
 
            The real goal of the method validation process is to challenge the method and 
determine limits of allowed variability for the conditions needed to run the method. It 
is important to have a well-conceived  validation plan for testing the method and 
acceptance criteria before starting the validation process. Included in this plan should 
be detailed procedure describing  the entire  method  (including  calibration  standard  
and  sample preparation, separation, data handling and calculations) that can 
conveniently be executed by others. 
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Parameters for Validation of HPLC Methods14-15 
 
The validation parameters as per ICH guidelines and USP are:- 
Table: 1. validation parameters as per ICH guidelines and USP 
 
1.System Suitability 6. Limit of Quantitation 
2. Accuracy 7. Limit of Detection 
3. Precision 8. Ruggedness 
4. Linearity &  Range 9. Robustness 
5. Specificity 10. Stability 
 
 
A. ACCURACY: 
Accuracy is the closeness of test results obtained by that method to the true 
value. 
Determination of accuracy 
In case of assay of a drug substance accuracy may be determined by 
application of the analytical method to an analyte of known purity (e.g. reference 
standard) or by comparison of the results of the method with those of a second 
well characterized method, the accuracy of which has been stated or defined.  
Accuracy is calculated as the percentage of recovery by the assay of the known 
added amount of analyte in the sample, or as the difference between the mean and 
the accepted true value, together with confidence intervals. 
The ICH documents recommended that accuracy should be assessed using 
a minimum of nine determinations over a minimum of three concentrations levels, 
covering the specified range (i.e., three concentrations and three replicates of each 
concentration). 
 
B. PRECISION: 
Precision is the degree of agreement among individual test results when 
the method is applied repeatedly to multiple samplings of a homogenous sample.  
Precision of an analytical method is usually expressed as the standard deviation or 
relative standard deviation (coefficient of variation) of a series of measurements. 
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Precision may be measure of either the degree of reproducibility or of 
repeatability of the analytical method under normal operating conditions. 
Determination of precision 
Precision of an analytical method is determined by assaying a sufficient 
number of aliquots of a homogenous sample to be able to calculate statistically 
valid estimates of standard deviation or relative standard deviation (coefficient of 
variation).  The ICH documents recommend that repeatability should be assessed 
using a minimum of nine determinations covering the specified range for the 
procedure. 
 
Bias (Systematic error) 
Indicative of tendency of the method to measure something other than 
what it is intended to measure. 
Repeatability 
The precision of the analytical method when repeated by the same analyst 
under set of laboratory conditions, the only difference being the sample. 
Determination of repeatability 
The repeatability of a test procedure is assessed by carrying out complete 
separate determinations on the separate samples of the same homogeneous batch 
of the material and this will provide a measure of the precision of the procedure 
under normal laboratory operating conditions. 
Reproducibility 
When the procedure is carried out by different analysts in different 
laboratories, using different   equipments, reagents and laboratory setting. 
Determination of reproducibility 
The reproducibility of a test procedure is determined by evaluating the 
samples from the same homogeneous batch, the analytical data will provide 
information about the reproducibility of the test procedure under validation. 
 
C. SPECIFICITY: 
ICH documents defines specificity as the ability to assess unequivocally 
the analyte in the presence of compounds that may be expected to present, such as 
impurities, degradation products and matrix components. 
Identification tests 
Ensure the identity of an analyte. 
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           Purity test 
Ensure that all the analytical procedures performed allow an accurate 
statement of the content of impurities of an analyte. (e.g., related substances test, 
heavy metals limit, organic volatile impurity test). 
Assay 
Provide an exact result, which allows as accurate statement on the content 
or potency of the analyte in a sample. 
Determination of specificity 
ICH documents state that when chromatographic procedures are used, 
representative chromatograms should be presented to demonstrate the degree of 
selectivity and peaks should be appropriately labeled. Peak purity tests (e.g., 
Using diode array or mass spectrometry) may be useful to show that the analyte 
chromatographic peak is not attributable to more than one component. 
D. DETECTION LIMIT(LOD): 
Lowest amount of analyte in a sample that can be detected, but not 
necessarily quantities as an exact value, under the stated experimental conditions.  
The detection limit is usually expressed as the concentration of analyte (e.g., 
percentage parts per million) in the sample. 
D L = 3.3 σ/ S 
Where; 
 σ = the standard deviation of the response, 
S = the slope of the calibration curve, 
DL = Detection Limit. 
The slope S may be estimated from the calibration curve of the analyte. 
            
     Determination of detection limit 
 
For instrumental and non-instrumental methods detection limit is generally 
determined by the analysis of samples with known concentration of analyte and by 
establishing the minimum level at which the analyte can be reliably detected. 
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E. QUANTITATION LIMIT(LOQ): 
It is the lowest amount of analyte in a sample that can be determined with 
acceptable precision and accuracy under the stated experimental conditions. 
Quantitation limit is expressed as the concentration of analyte (e.g. percentage, 
parts per billion) in the sample. 
 
Determination of quantitation limit 
For instrumental and non-instrumental methods, the quantitation limit is generally 
determined by the analysis of samples with known concentration of analyte and by 
establishing the minimum level at which the analyte can be determined with 
acceptable accuracy and precision. 
QL=10 s/ S 
Where’ 
 s = the standard deviation of the response, 
S = the slope of the calibration curve, 
QL = Quantitation limit. 
The slope S may be estimated from the calibration curve of the analyte. 
 
F. LINEARITY AND RANGE: 
Linearity of an analytical method is its ability to produce results that are 
directly proportional to the concentration of analyte in samples.  The range of the 
procedure is an expression of the lowest and highest levels of analyte that have 
been demonstrated to be determinable with acceptable precision, accuracy and 
linearity. 
 
Determination of linearity and range 
These characteristics are determined by application of the procedure to a 
series of samples having analyte concentration spanning the claimed range of the 
procedure. When the relationship between response and concentration is not 
linear, standardization may be provide by means of a calibration curve.  ICH 
recommends that for the establishment of linearity a minimum of 5 concentrations 
normally used. 
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G. SENSITIVITY: 
Sensitivity is the capacity of the test procedure to record small variations 
in concentration. It is the slope of the calibration curve.  A more general use of the 
term to encompass limit of detection and or / limit of quantitation should be 
avoided. 
 
 
H. RUGGEDNESS: 
Degree of reproducibility of test results obtained by the analysis of the 
same samples under a variety of conditions, such as different laboratories, 
different analysts, different instruments etc., normally expressed as the lack of 
influence on test results of operational and environmental variables of the 
analytical method. Ruggedness is a measure of reproducibility of test results under 
the variation in condition normally expected from laboratory to laboratory and 
from analyst to analyst. 
 
Determination of ruggedness 
 
By analysis of aliquots from homogenous lots in different laboratories, by 
different analysts, using operational and environmental conditions that may differ 
but are still within the specified parameters of the assay. Degree of reproducibility 
of test results is then determined as a function of the assay variables. 
 
I. ROBUSTNESS: 
Robustness of an analytical method is measure of its capacity to remain 
unaffectedly small but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage. 
 
J. SYSTEM SUITABILITY: 
According to USP system suitability are an integral part of 
chromatographic methods.  These tests verify that the resolution and 
reproducibility of the system are adequate for the analysis to be performed.  One 
consequence of the evaluation  robustness and ruggedness should be that a series 
of system suitability parameters is established to ensure that the validity of the 
analytical method is maintained whenever used.  System suitability tests are based 
on the concept that the equipment, electronics, analytical operations and samples 
constitute an integral system that can be evaluated as a whole.  
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SYSTEM SUITABILITY PARAMETERS FOR HPLC
Retention time (RT) 
Retention time is time of elution of peak maximum after injection of sample.
Column Efficiency (N) 
Solutes are placed on an HPLC 
 Each solute band spreads as it moves through the column due to diffusion 
and mass transfer affects
 The later eluting bands will spread more
 Peak shape follow a Gaussian distribution 
 The sharpness of a chromatographic peak is an 
the chromatographic column.
 Peak sharpness is determined by measurement of the peak width
 Peak width is dependent on flow rate so measurement of the width  alone 
is not enough 
 A good measure of column efficiency is
n = 16 (
w = width of the peak at its base, obtained by extrapolating the relatively      
straight sides of the peak to the baseline
w1/2 = width of the peak at half height, obtained directly by electronic 
integrators. 
 The value of ‘N’ depends upon the substance being chromatographed as well as 
the operating conditions such as mobile phase, temperature etc
 
Resolution (RS)  
It is function of column efficiency, and is specified to ensure that closely eluting 
compounds are resolved from each other to establish the general resolving power of 
system. 
The separation of two components in a mixture the resolution is determined by the 
equation, 
 
16
 
column in a narrow band 
 
 
 
indication of the quality of 
 
. 
) 2 or n = 5.54 (  ) 2 
. 
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Where, tR(2) and tR(1)  are the retention time of second and first compound              
respectively, where as W2 and W1 are the corresponding widths at the base of peaks 
obtained by extrapolating straight side of peaks to the base lines.
Where, electronic integrator is used, it may be convenient to determine the resoluti
equation 
                                              R
Where, W h/2 is peak at the half height, obtained directly by electronic integrator.
Peak Asymmetric factor or Tailing (As)
A properly packed HPLC column will give symmet
Changes in either the physical or chemical integrity of the column bed can lead to peak 
tailing.  
 
 
 
 
T = 
 
tR(2) – tR(1)                              
---------------- 
W1 + W2) 
 
S =        
 
rical or gaussian peak shapes. 
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Where W0.05 is the width of peak at 5% height and f is the distance from the peak 
maximum to the leading edge of the peak height from the baseline.
 
Tailing can be caused by: 
 Column voids, channels, or extra
peaks most)
 Stripping of the bonded phase (affects late eluting peaks most)
Separation Factor (α) 
 The separation factor, also referred to as column selectivity, is affected by 
changes in the chemistry of the chromatographic method such as:
 A change in the choice of solvents for the mobile phase
 A change in the packing material in the column
 Because we are 
component, a term describing the separation of peaks is needed.
 The separation factor describes the relative position of two peak maxima
 It is equal to the ratio of the time each component spen
                                                      
This equation is more often seen as the ratio of the capacity factors
Capacity factor (k') 
 It is the measure of how well the sample molecule is retained by the column 
during an isocratic separation. It is affected by solvent composition, separation and aging 
and temperature of separation. 
      
 
 
 
-column dead volume (affects early eluting 
 
 
 
 
 
usually dealing with samples that contain more than one sample 
 
ds on the packing material
 α =   
 
α =   
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Retention Factor 
       tR-t0  
K= ----------                                                                 
          t0 
Where, tR = retention volume at the apex of the peak (solute) and  
t0 = void volume of the system.  
Peak Width 
Due to the nature of the chromatographic equipment a dilution of the injected 
sample solution occurs when the sample molecules migrates through the column. As a 
consequence the zone containing the sample molecules broadens continually during its 
passage through the column. The detector will register a peak with a certain width. The 
measure for the peak width is the height of a theoretical plate.   
System Suitability Parameters and Recommendations 
Parameter   Recommendation  
Capacity Factor (k’) The peak should be well-resolved 
from other peaks and the void volume, generally k’>2.0  
Repeatability                         RSD </= 1% for N >/= 5 is desirable.  
Relative retention                   Not essential as long as the resolution is stated.  
 
Resolution (Rs)                      Rs of > 2 between the peak of interest and the closest eluting     
potential interferent (impurity, excipient, degradation 
product, internal standard, etc.  
Tailing Factor (T)                    T of </= 2  
Theoretical Plates (N)              In general should be > 2000 
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STATISTICAL PARAMETERS  
Linear regression  
 Once a linear relationship has been shown to have a high probability by the value 
of the correlation coefficient ‘r’, then the best straight line through the data points has to 
be estimated. This can often be done be done by visual insp
graph, but in many cases it is far more sensible to evaluate the best straight line by linear 
regression (the method of least squares).
The equation of straight line is 
y = mx + c 
Where, y the dependent variable is plotted as res
variable. 
 To obtain the regression line ‘y on x’ the slope ‘m’ of the line and the intercept ‘c’ 
on the y axis are given by the following equation.
 m =  
 
Correlation coefficient 
To establish whether there is a linear relationship between two variables x1 and y1
Pearson’s correlation coefficient r.
                     r = 
Where n is the number of data points.
 The value of r must lie between +1 and 
probability that a definite linear relationship exists between the variables x and y, values 
close to +1 indicate positive correlation and values close to 
correlation values of ‘r’ that tend towards zero ind
related (they made be related in a non
 
 
 
 
ection of the calibration 
 
 
ult of changing x, the independent 
 
 and   c =  
 
 
 
-1, the nearer it is to +1, the greater the 
-1 indicate negative 
icate that x and y are not linearly 
-linear fashion). 
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Standard deviation 
 It is commonly used in statistics as a measure of precision statistics as a measure 
of precision and is more meaningful than is the average deviation. It may be thought of 
as a root-mean-square deviation of values from their average and is expressed 
mathematically as 
( )
1N
xx
S
ni
1i
i
−
−
=
∑
=
=
 
Where,  
S is standard deviation. 
If N is large (50 or more) then of course it is immaterial whether the term in the 
denomination is N -1 or N  
Σ       = sum 
x       = Mean or arithmetic average 
x -x  = deviation of a value from the mean 
N      = Number of observations 
 
Percentage relative standard deviation (%RSD) 
 It is also known as coefficient of variation CV. It is defined as the standard 
deviation (S.D) expressed as the percentage of mean. 
 
             
Where,  
 S.D   = standard deviation, 
x       = Mean or arithmetic average. 
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 The variance is defined as S2 and is more important in statistics than S itself.    
However, the latter is much more commonly used with chemical data. 
Standard error of mean (S.E.) 
 Standard error of mean can be defined as the value obtained by division of 
standard deviation by square root of number of observations. It is mathematically 
expressed as 
n
S.D.S.E. =
 
Where, 
  S.D = Standard deviation 
n = number of observations. 
 
Chapter: 2                                                                                                       Literature Review 
 
R.V.S. College of Pharmaceutical Sciences, Coimbatore  Page 33 
 
2.  LITERATURE  REVIEW 
 
 Zarna Dedania et al . , 17  (2009) developed an RP-HPLC method for 
simultaneous estimation of omeprazole and ondansetron in combined tablet dosage 
forms. The separation was carried out on RP C18 (250×4.6,5µ) using mobile phase 
consisting of Methanol:Acetonitrile (90:10). The retention times for omeprazole and 
ondansetron was found to be 5.39 and 11.08 min respectively. The detection was 
carried out at 218 nm using PDA detector. The linearity concentration was in the 
range of 4-20µg/ml of Omeprazole and Ondansetron respectively. The method has 
been validated as per ICH guidelines. 
 
 Kiriti S Topagi et al . , 18 (2010) have developed and validated HPLC method 
for simultaneous determination of drotaverine hydrochloride and omeprazole in tablet 
dosageforms. Seperation was achevied on HiQsil using UV detector. The mobile 
phase consists of n-heptane : dichloromethane : methanolic ammonia(5%) : methanol 
(50:25:1:4) at flow rate of 1.0ml/min. The retention times of drotaverine 
hydrochloride and omeprazole were found to be 6.0 and 8.1 respectively. The 
linearity of drotaverine and omeprazole were found in the concentration range of 10-
50µg/ml and 2.5-12.5µg/ml. 
 
 Nayan M Jagani et al . , 19 (2012) developed simple,sensitive dual 
wavelength spectrophotometric method for simultaneous estimation of Omeprazole 
and Cinitapride tartarate in combined capsule dosage forms. The determination was 
carried out at 288 nm and 312.9 nm. The linearity results were obtained in the 
concentration range of 10-30 µg/ml and 1.5-4.5 µg/ml for omeprazole and cinitapride. 
The sutability of the method for quantitative determination was proved by validation. 
 
 Patel G.H et al . , 20 (2012) developed and validated an HPLC method for 
simultaneous estimation of Cinitapride and Pantaprazole in pharmaceutical dosage 
forms. Chromatographic separation was achieved isocratically on inertsil C18 
(250×4.6, 5µ). The mobile phase consisting of acetonitrile : phosphate buffer (80:20 
v/v, pH 6.8).The Flow rate was 1.0 ml/min. The uv detection was carried out at 278 
nm. The retention times times of  Cinitapride and Pantaprazole was 3.18 min and 4.72 
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min respectively. The method is linear within the range of 1.5-12 µg/ml and 20-
160µg/ml for Cinitapride and Pantaprazole .The LOD of Cinitapride and Pantaprazole 
was 0.064 µg/ml and 0.78 µg/ml while LOQ was 0.205µg/ml and 2.38µg/ml 
respectively. 
 
 Y.V. Rami Reddy et al  . ,21 (2012) have done work on development and 
validation of HPLC method for simultaneous determination of Omeprazole and 
Domperidone in tablets .The mobile phase consists of acetonitrile : phosphate buffer 
(60:40v/v pH 7) at flow rate of 1.0 ml/min and separation was achieved on C18 
Nucleosil column using internal standard diphenylamine.The retention times of 
omeprazole and domperidone are 3.64 and 4.31 respectively. 
 
 Hemant Kumar Jain et al . , 22(2012) developed RP-HPLC method for 
simultaneous estimation of Pantaprazole and Cinitapride in capsule formulation. The 
separation was carried out on chromatopak peerless LC-C18 column with mobile phase 
consisting of methanol :phosphate buffer(98:02 % v/v, pH 7). The flow rate was 0.6 
ml/min and detection was carried at 280 nm. The retention times of pantaprazole and 
cinitapride are 4.8 and 6.2 min respectively. Linearity for pantaprazole and cinitapride 
was found in the range of 250-560 and 18-42 µg/ml. 
 
 Devika P Chauhan et al . , 23 (2012) developed and validated an HPTLC 
method for simultaneous estimation of cinitapride and omeprazole. The determination 
was carried on silicagel 60 gf254 hptlc plates using mobile phase consisting of 
toluene : ethylacetate : methanol : acetic acid (6:3:1:01v/v/v/v). The absorbance of 
spots was measured by densitometry at 289 nm. The Rf of cinitapride and omeprazole 
are 0.48 and 0.75 respectively. The linearity of cinitapride and omeprazole were 
found in the concentration range of 100-600ng and 15-90 ng/band respectively. 
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 Y.G. Makani et al . , 24 (2012) have done and development and validation of 
first order derivative spectrophotometric method for simultaneous estimation 
omeprazole and cinitapride in combined dosage forms. The detection was carried out 
at 263.2 for omeprazole and253.8 for cinitapride. The method was linear in the range 
of 7-42µg/ml for omeprazole and 1-6µg/ml for cinitapride. The method is valdated as 
per ICH guidelines. 
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                                        3.DRUG PROFILE  
  3.1  DRUG PROFILE 
 
(a)  Omeprazole 
 
 Molecular struture : 
N
H
N
S N
O
O
O
 
                                         
Molecular Formula  :   C17H19N3O3S 
Chemical Name        :    6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2yl)methane]                          
                                        Sulfinyl}-1H-1,3 benzodiazole 
Molecular Weight    :    345.4g/mole 
Category                   :    Anti-ulcer agent,proton pump inhibitor 
  Physical properties : 
Colour             :   White 
Melting point   :  1560c 
Solubilty           :  Water    
  Clinical  pharmacology : 
Mode of action : 
                         Omeprazole is a proton pump inhibitor that suppresses gastric acid 
secretion by specific inhibition of the H+/K+-APTase in the gastric parietal cell .By 
acting specifically on the proton pump ,Omeprazole blocks the final step in acid 
production thus reducing gastric acidity 
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 (b) Cinitapride 
    Molecular structure: 
        
O
H2N
NO2
N
H
NO
                                                       
        Molecular formula       :       C21H30N4O4 
Molecular weight         :        402.49g/ml 
Category                       :       Antiemetics 
Chemical name             :        (RS)-4-amino-N-[1-(1-cyclohex -3-enylmethyl)-4                                                            
                                                - piperidyl]-2-ethoxy-5-nitro-benzamide 
Physical properties 
State                              :   Solid 
Colour                           :    White 
Melting point                :     152-1540c 
 Solubility                     :     Acetonitrile ,Methanol 
                       
Clinical pharmacology: 
Mode of action: 
                        Acts via inhibition of serotonergic 5-HT2 and Dopaminergic D2 receptor and                             
 Stimulation of serotonergic 5-HT4 receptors in the neuronal synapses of the myenteric 
plexi                                  
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                                AIM AND OBJECTIVE 
Literature review survey revealed that sevaral methods have been reported for 
simultaneous estimation of Omeprazole and Cinitapride individually or in 
combination with other methods so far HPTLC, HPLC methods,have been developed. 
However no sensitive HPLC methods have been developed for simultaneous 
estimation of  Omeprazole and Cinitapride. 
              Aimed to develop analytical method development and validation for 
Omeprazole and Cinitapride in pharmaceutical dosage form. 
 Objective: 
  To develop simple, rapid, and sensitive chrmatographic mehod for 
determination of     
  Omeprazole and Cinitapride in pharmaceutical dosage forms. 
• Quantitative determination ,a trace level when necessary, i.e accurate ,precise 
and   reproducible in any laboratory setting. 
• Ease of use ,ability to be automated ,high sample through put, and rapid turn 
around   time. 
• To develop a method it is necessary to consider the properties of the analyte 
of    interest that may be used to advantage and to established optimal ranges 
of analyte  parameter values. 
• It is important that method development be performed using only analytical 
standard     that have been well identified and characterized and whose purity 
is already known. 
• The developed method is to be validated according to ICH and USP 
guidelines. 
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                              5.  EXPERIMENTAL 
 
5.1. MATERIALS AND INSTRUMENTS 
 
5.1.1. Instruments: 
Table No 2: Table showing list of the Instruments used 
 
 
S. No 
 
 
Name of the 
Instrument 
 
Manufacturer 
 
Model 
 
1. 
 
 
HPLC 
 
Water 
 
Alliance-2695 
PDA Waters-2996 
 
 
2. 
 
 
Electronic balance 
 
Shimadzu 
 
AY 220 
 
3. 
 
 
Digital pH
 
meter 
 
Digisun Electronics 
 
7007 
 
4. 
 
Centrifuge 
 
Thermolab 
 
R8C 
 
 
5. 
 
 
Ultrasonicate water 
bath 
 
 
_________ 
 
 
Ultrasonicate SECOUS 
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5.1.2. Reagents and chemicals: 
Table No 3: Table showing list of the chemicals used 
 
S. No 
 
Name 
 
 
Grade 
 
 
Manufacturer/ 
Supplier 
 
1. Omeprazole & Cinitapride working   
standard 
 
- 
 
- 
 
2. 
 
Potassium dihydrogen phosphate 
 
 
HPLC 
 
Merck 
 
3. 
 
Acetonitrile 
 
 
HPLC 
 
Merck 
 
4. 
 
 
Milli Q Water 
 
HPLC 
 
- 
 
5.2.  METHOD DEVELOPMENT AND OPTIMIZATION OF OMEPRAZOLE AND 
           CINITAPRIDE 
1. SELECTION OF DETECTOR WAVE LENGTH: 
The wave length selection is made at 215 nm since all the two compounds shows 
maximum absorbance in UV spectrum as reported in the literature. 
2. OPTIMIZED CHROMATOGRAPHIC CONDITIONS: 
a. Selection of mode of separation: 
         As the drug was polar in nature, RP-HPLC method was preferred. 
Procedure: 
Preparation of Buffer solution: 
Dissolve 13.6 g of Potssium dihydrogen phosphate  into a 1000 ml beaker with 
HPLC  water. The  pH was 6.5 . 
Preparation of mobile phase: 
Mix a mixture of above buffer 600mL (60%) and 400 mL of Acetonitrile HPLC 
(40%) and degas in ultrasonic water bath for 5 minutes. Filter through 0.45 µ filter under 
vaccum filtration. 
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Preparation of diluent: 
              Dissolve 13.6 g of Potssium dihydrogen phosphate  into a 1000 ml beaker with 
HPLC  water. Transfer 500 ml of above solution and 500 ml of acetonitrile in 1000 ml 
beaker, mix and sonicate for 15 minitues. 
Preparation of Standard Solution: 
                Accurately 20mg of Omeprazole & 15mg of Cinitapride  were weighed and 
transferred into 20ml volumetric flask, about 10ml of NaoH was added and sonicated for 
5 minutes to dissolve it. The volume was made up diluent. The solution was filtered 
through 0.45µm membrane filter. 
                 From this pipette out  5.0ml of solution and transferred into 100ml of 
volumetric flask and the volume was made up with diluent(stock solution). 
                   From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter(standard solution). 
                  Inject 50 µl of the standard solution into the chromatographic system and 
measure the area for the Omeprazole & Cinitapride peaks and calculate the %Assay by 
using the assay formula. 
TRIAL&ERROR METHODS: 
TRIAL -1: 
CHROMATOGRAPHIC CONDITIONS: 
Column                    :  Kromosil C18 (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                   : 215nm 
Flow rate                 : 1.0 ml/min 
Injection volume     : 50µl 
Run time                 : 14min 
Mobile Phase          : Buffer (pH: 6.5): Acetonitrile (50: 50) 
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Trail-1 
Fig No: 5.2.1 
Results of Trial-1: Peak shapes are not good, so another trail is made by changing the 
column 
TRIAL- 2: 
CHROMATOGRAPHIC CONDITIONS: 
Column                         : Hypersil BDS C18 (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                        : 215nm 
Flow rate                      : 1.0ml/min 
Injection volume          : 50µl 
Run time                      : 16min 
Mobile phase               : Buffer (pH-.6.5): Acetonitrile(50:50) 
Trail – 2 
Fig No: 5.2.2 
 
AU
0.00
0.20
0.40
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00
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0.20
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Results of Trial-2: Peaks are merged, so another trial is made by changing the mobile 
phase ratio. 
Trail-3: 
CHROMATOGRAPHIC CONDITIONS: 
 
Column                         : Hypersil BDS C18 (4.6 x 150mm, 5 µm, Make: ACE) 
Detector                        : 215nm 
Flow rate                       : 1.0ml/min 
Injection volume            : 50µl 
Run time                        : 6min 
Column temperature      : 40°c 
Mobile phase               : Buffer (pH-6.5): Acetonitrile (60:40) 
 
Fig No:5.2.3 
 
Results of Trial-3: Peak shape was good but theoretical plates are not passed, so  
another trail is made. 
Final method: 
Column                         : Hypersil BDS C
 18 (4.6 x 250mm, 5 µm, Make: ACE) 
Detector                        : 215nm 
Flow rate                       : 1.0ml/min 
Injection volume            : 50µl 
AU
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0.20
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0.00 1.00 2.00 3.00 4.00 5.00 6.00
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Run time                        : 6min 
Column temperature      :  40°c 
Mobile phase               : Buffer (pH-.6.5): Acetonitrile (60:40) 
Fig No:5.2.4 
 
 
Results of Trial-4(Final Optimized Method):  
RT’s were observed at 2.391 (Omeprazole), and 4.602 (Cinitapride). The peaks 
are sharply resolved and hence the trial-4 method is optimized for analysis. 
 
5.2.1 ANALYTICAL METHOD-OPTIMISATION 
Aim: The present study is to develop a new reverse phase liquid chromatographic 
method for simultaneous determination of Omeprazole & Cinitapride in capsule dosage 
form. 
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Table No : 4 Table showing Optimized Chromatographic Parameters 
OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
Mode of separation Isocratic elution 
Mobile phase Solvent-A: Potassium dihydrogen 
phosphate buffer pH-6.5 
Solvent-B: Acetonitrile 
Column Hypersi BDS (4.6 x 250mm, 5 µm, 
Make: ACE)(60:40) 
Flow rate 1.0 mL/ min 
Detection  Wavelength 215 nm 
Injection volume 50 µl 
Column oven temperature 40°C 
Run time 6 min 
 
Fig No: 5.2.5 Chromatogram showing peaks of standard solution of 
Omeprazole and Cinitapride 
 
Peak name RT Area Plate count Resolution Tailing 
Omeprazole 2.391 12514807 4025 11.313 1.544 
Cinitapride 4.602 2150791 6382 
 
1.356 
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5.2.2 QUANTITATIVE DETERMINATION OF THE DRUG BY USING THE 
DEVELOPED METHOD 
Sample :  Omeprazole and Cinitapride 
Label claim : 20,3 mg 
Standard Solution : 
Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed and transferred 
into 20ml volumetric flask, about 10ml of sodium hydroxide was added and sonicated for 
5 minutes to dissolve it. The volume was made up diluent. The solution was filtered 
through 0.45µm membrane filter. 
From this pipette out 5.0ml of solution and transferred into 100ml of volumetric flask and 
the volume was made up with diluent  
From this 5.0ml of solution was pipette out and transferred into 25ml of volumetric flask 
and the volume was made up with mobile phase. The solution was filtered through 
0.45µm membrane filter  
Inject 50 µl of the standard solution into the chromatographic system and measure the 
area for the Omeprazole and Cinitapride peaks and calculate the %Assay by using the 
assay formula. 
 
Sample Solution Omeprazole & Cinitapride 
                   20 Omeprazole and Cinitapride capsules(Burpex) were weighed and the 
average weight was calculated. Accurately the sample equivalent to 20mg of Omeprazole 
& 15 mg of Cinitapride was weighed and transferred into 20ml volumetric flask about 
10ml of Sodium hydroxide was added and sonicated for 5 minutes to dissolve it content. 
The volume was made up with diluent. The solution was filtered through 0.45µm 
membrane filter. 
                   5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
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                    5.0ml of stock solution was pipetted out and transferred into 25 ml of 
volumetric flask and the volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter. 
                    Inject 50 µl of the standard solution into the chromatographic system and 
measure the area for the Omeprazole and Cinitapride peaks and calculate the %Assay by 
using the assay formula. 
 
Assay formula: 
AT               WS           DT 
--------------- x ----------x --------- x average weight of tablet 
AS              DS           WT 
Where, 
AT = Peak Area of sample solution. 
AS = Peak Area of standard solution. 
WS = Weight of working standard taken in mg 
WT = Weight of sample taken in mg 
DS = Dilution of Standard solution 
DT = Dilution of sample solution 
Acceptance criteria: The limit of assay is in between the 98% - 102% 
The chromatograms are as shown in Fig No 5.2.6 and 5.2.7  and assay results are 
tabulated and are as shown in Table No: 5 
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Chromatogram showing peaks of standard solution of Omeprazole and Cinitapride. 
Fig No 5.2.6 
 
 
Peak name RT Area Plate count Resolution Tailing 
Omeprazole 2.391 12514807 4025 11.313 1.544 
Cinitapride 4.602 2150791 6382 
 
1.356 
 
Chromatogram showing peaks of test solution of Omeprazole and Cinitapride. 
Fig No : 5.2.7 
 
 
Peak name RT Area Plate count Resolution Tailing 
Omeprazole 2.390 12530126 3976 11.331 1.575 
Cinitapride 4.601 2149391 6365 
 
1.356 
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Table showing Assay Results of Omeprazole & Cinitapride : 
Table No: 5 
 
S. No Compound name Assay value 
1. Omeprazole 98.56% 
2. Cinitapride 99.1% 
 
5.3 VALIDATION 
Definition: Validation is a process of establishing documented evidence which provides a 
high degree of assurance that a specific process will consistently produce meeting, its 
predetermined specifications and quality attributes. 
 
The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated. Typical validation 
characteristics which should be considered are listed below. 
 
• Accuracy 
• Precision 
• Specificity 
• Linearity & Range 
• Robustness 
• System suitability testing 
 
After method development, the validation of the current method has been 
performed in accordance with USP requirements for assay determination (Category-I: 
analytical methods for quantitation of active ingredients in finished pharmaceutical 
products) which include accuracy, precision, selectivity, linearity and range, robustness 
and ruggedness. 
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5.3.1   SYSTEM SUITABILITY TESTING 
                         System suitability testing is an integral part of many analytical 
procedures. The tests are based on the concept that the equipment, electronics, analytical 
operations and samples to be analyzed constitute an integral system that can be evaluated 
as such. System suitability test parameters to be established for a particular procedure 
depend on the type of procedure being validated and the parameters like tailing factor, 
retention time, theoretical plates per unit, resolution factor are determined and the results 
are tabulated and are as shown in Table No: 6 
Method 
Preparation of Standard solution: 
Standard Solution Omeprazole and Cinitapride: 
                 Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed and 
transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added and 
sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution was 
filtered through 0.45µm membrane filter. 
                   From this pipette out 5.0ml of solution and transferred into 100ml of 
volumetric flask and the volume was made up with diluent . 
                   From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
                    Inject 50 µl of the standard solution into the chromatographic system and 
measure the area for the Omeprazole and Cinitapride peaks and calculate the %Assay by 
using the assay formula. 
 
           Acceptance criteria: 
a. The column efficiency is not less than 2000 theoretical plates. 
b. The tailing factor for the analyte peak is not more than 2.0. 
c. The relative standard deviation for the replicate injections should not more than 2.0%. 
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Chromatograms showing system suitability testing of Standard Solutions of 
Omeprazole and Cinitapride. 
Fig No : 5.2.8 
 
Fig No : 5.2.9 
 
Fig No : 5.2.10 
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Fig No: 5.2.11 
 
Fig No : 5.2.12 
 
 
Table showing list of system suitability parameters of Omeprazole and Cinitapride. 
 
Table No : 6 
 
Parameters Omeprazole Cinitapride 
Tailing factor 1.5 1.3 
Retention time 2.39 4.603 
Theoretical plates per unit 3985.6 6413.2 
% RSD 0.32 0.21 
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5.3.2. ACCURACY 
The accuracy of an analytical method is the closeness of that results obtained by 
that method to the true value. Accuracy may often be expressed as percent recovery by 
the assay of known added amount of analyte. 
Determination: 
The accuracy of the analytical method was determined by applying the method to 
the analyzed samples, to which known amounts of analyte had been added. The accuracy 
was calculated from the test results as the percentage of analyte recovered by the assay. 
Procedure: 
Preparation of Standard solution : 
                        Accurately 20mg of Omeprazole and 15mg of Cinitapride were weighed 
and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added 
and sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution 
was filtered through 0.45µm membrane filter. 
           From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent . 
           From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter . 
Preparation of 50% sample solution: 
                         Accurately 10mg of Omeprazole and 7.5mg of Cinitapride  were weighed 
and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added 
and sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution 
was filtered through 0.45µm membrane filter. 
              From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent . 
               From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter . 
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Preparation of 100% solution: 
                        Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed 
and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added 
and sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution 
was filtered through 0.45µm membrane filter. 
                From this pipette out 5.0ml of solution and transferred into 100ml of 
volumetric flask and the volume was made up with diluent . 
                From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter  
Preparation of 150% solution: 
                        Accurately 30 mg of Omeprazole and 22.5mg of Cinitapride  were 
weighed and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide 
was added and sonicated for 5 minutes to dissolve it. The volume was made up diluent. 
The solution was filtered through 0.45µm membrane filter. 
               From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent  
              From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter  
                Inject 50µl of placebo and standard solutions of Accuracy -50%, Accuracy -100% 
and Accuracy -150% solutions into HPLC. Now calculate the amount obtained and amount 
added (API) for Omeprazole and Cinitapride  samples. 
Calculate the concentration in µg/ml in the spiked placebo in all the above cases by 
comparing with the standard solution. Calculate the individual recovery and mean 
recovery values. The chromatograms are as shown in Fig. No: 5.2.13-5.2.15 and the 
results are tabulated and shown in Table No: 7 
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Formula:                                             
                                                                (Amount recovered) 
%recovery     =                                                                                 × 100 
                                                                (Actual amount added) 
Acceptance criteria: 
Percentage recovery in all the cases should be between 98.0 and 102.0 %. 
 
Chromatogram showing Accuracy 50% of Omeprazole & Cinitapride. 
Fig No : 5.2.13 
 
 
 
Peak name RT Area 
Omeprazole 2.390 6205503 
Cinitapride 4.606 1057276 
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Chromatogram  showing Accuracy -100% of Omeprazole and Cinitapride 
Fig No :5.2.14 
 
 
Peak name RT Area 
Omeprazole 2.387 12281570 
Cinitapride 4.599 2138513 
 
Chromatogram  showing Accuracy – 150% of Omeprazole and Cinitapride                          
Fig No : 5.2.15 
 
 
Peak name RT Area 
Omeprazole 2.391 17879545 
Cinitapride 4.597 3138845 
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Table showing results of % Recovery studies for Omeprazole and Cinitapride 
Table No : 7 
 
5.3.3 PRECISION 
Precision of an analytical method is the degree of agreement among individual 
test results when the procedure is applied repeatedly to multiple sampling of a 
homogenous sample. Precision of analytical method is usually expressed as the standard 
deviation and relative standard deviation. 
Determination: 
The precision of the analytical method was determined by assaying sufficient 
number of samples and relative standard deviation was calculated. 
The precision of the instrument was determined by assaying the samples 
consecutively, number of time and relative standard deviation was calculated. 
 
 
 
Inj. Sample Spike Level 
Amount 
present 
in µg 
Amount 
recovered 
 
%  
recovered 
Mean 
recovery 
 
%RSD 
Acceptance 
Criteria 
Omeprazole 
50 %     5 4.97mg 99.4% 
 
99.16% 
 
 
0.373 
 
 
 
98-102% 
100 
%    10 9.83mg 98.3% 
150 
%    15 14.97mg 99.8% 
Cinitapride 
50 %    3.75 3.72mg 99.2% 
99.3%.5 
 
 
0.254 
 
 
 
98-102% 
100 
%    7.5 7.43mg 99.0% 
150 
%    10.25 10.23mg 99.8% 
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A) System Precision: 
Preparation of Standard Solution : 
                      Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed 
and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added 
and sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution 
was filtered through 0.45µm membrane filter. 
            From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent  
            From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter  
             Inject 50µl of the blank solution and the standard solution of for six times and 
calculate the %RSD for the area of six replicate injections.The chromatograms are as shown 
in Fig No: 5.2.17-5.2.22 and the results are tabulated shown in Table No:8. 
Blank solution: Mixture of  phosphate buffer (pH6.5) and acetonitrile  in ratio of 60:40 was 
filtered and degassed. 
 
System Precision: 
Chromatogram showing Precision-blank solution. 
Fig No : 5.2.16 
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Chromatogram showing Precision of Standard Preparation-1 for Omeprazole and 
Cinitapride 
Fig No : 5.2.17 
 
Peak name RT Area 
Omeprazole 2.388 12490568 
Cinitapride 4.602 2137140 
 
Chromatogram showing Precision of Standard Preparation-2 for Omeprazole and 
Cinitapride 
Fig No : 5.2.18 
 
Peak name RT Area 
Omeprazole 2.389 12514086 
Cinitapride 4.605 2149337 
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Chromatogram showing Precision of Standard Preparation-3 for Omeprazole and 
Cinitapride 
Fig No : 5.2.19 
 
Peak name RT Area 
Omeprazole 2.390 12358502 
Cinitapride 4.605 2122528 
 
Chromatogram showing Precision of Standard Preparation-4 for Omeprazole and 
Cinitapride 
Fig No :5.2.20 
 
Peak name RT Area 
Omeprazole 2.388 12356161 
Cinitapride 4.601 2121834 
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Chromatogram showing Precision of Standard Preparation-5 for Omeprazole and      
Cinitapride 
Fig No :5.2.21 
 
Peak name RT Area 
Omeprazole 2.388 12342535 
Cinitapride 4.601 2119680 
 
Chromatogram showing Precision of Standard Preparation-6 for Omeprazole and 
Cinitapride 
Fig No :5.2.22 
 
  
Peak name RT Area 
Omeprazole 2.390 12391131 
Cinitapride 4.607 2152385 
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B) Method Precision: 
Preparation of Sample Solution: 
                            Accurately pipette out 5ml of the sample (equivalent to 20mg of Omeprazole  
and 15mg of Cinitapride) into a 100ml volumetric flask and 70ml of diluent was added 
and mixed well and made up to the mark with diluent. Mix well and filter through 
0.45µm filter. 
                        Pipette out 5.0ml of Omeprazole and Cinitapride from stock solution and 
transferred into 25ml of volumetric flask and the volume was made up with diluent 
             Inject 50µl of the blank solution and six replicate injections of sample solution   for 
six times and calculate the %RSD for the area of six replicate injections. 
 
                                        %RSD Formula:  (σ /µ)*100 
 
Acceptance criteria: % Relative standard deviation (%RSD) for the areas of Omeprazole 
and Cinitapride from the standard chromatograms should not be more than 2.0 
                   The method precision was determined by preparing the sample from the 
tablet formulation for five times and six successive injections of 50µl of working sample 
solution were injected and the chromatograms were recorded and shown in Fig No:5.2.23  
and method precision data are shown in table. 8 
Chromatogram showing Method Precision of  Omeprazole and Cinitapride 
    Fig No : 5.2.23 
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Peak name RT Area 
Omeprazole 2.390 12372131 
Cinitapride 4.601 2142685 
 
Table showing Results of Precision for Omeprazole and Cinitapride 
Table No : 8 
 
 
 
 
 
 
Intra Day Precision: 
Table No : 9 
Day Peak area of 
Omeprazole 
  Mean % RSD Peak area of  
Cinitapride 
  Mean % RSD 
 
1 
12523307  
12527767 
 
0.03 
  2149391  
2150732 
 
0.16 12530126   2149433 
12529869   2153372 
 
2 
12452352  
12452576 
 
0.01 
  2129671  
2129482 
 
0.29 12465893   2129984 
12439482   2128792 
 
3 
11469432  
11445887 
 
0.3 
  2091937  
2092015 
 
0.13 11466336   2094382 
11401894   2089726    
 
 
Parameter System Precision Method Precision 
Average 
Area 
Omeprazole Cinitapride Omeprazole Cinitapride 
  12408830  2152385  12352130 119524 
SD    74532    14612     74621 15752 
%RSD    0.68      0.72      0.64    0.82 
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Inter day Precission: 
Table No 10 : 
Time Peak area of 
Omeprazole 
  Mean % RSD Peak area of  
Cinitapride 
  Mean % RSD 
 
0th 
hour 
12523307  
12527767 
 
0.30 
  2149391  
2150899 
 
0.10 12530126   2149433 
12529869   2153372 
 
3rd  
hour 
12512352  
12516922 
 
0.28 
  2146871  
2147216 
 
0.16 12518931   2147984 
12519482   2146792 
 
6th 
hour 
12469432  
12465887 
 
0.38 
  2121937  
2124615 
 
0.13 12466336   2124382 
12461894   2127526    
 
5.3.4 SPECIFICITY: 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. 
Procedure: 
Preparation of placebo : 
           Placebo was prepared by mixing all the excipients without active ingredients. 
                   Accurately weighed  quantity of placebo was  transferred into 20ml 
volumetric flask, about 10ml of sodium hydroxide was added and sonicated for 5 minutes 
to dissolve it. The volume was made up with diluent. The solution was filtered through 
0.45µm membrane filter. 
                    From this 5.0ml of solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
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                     From this 5.0ml of solution was pipetted out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
              Inject 50 µl of Standard solution for six times into the HPLC system and  
chromatograph. 
Compare the chromatograms visually and check for any interference. 
Preparation of Standard solution : 
                 Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed and 
transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added and 
sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution was 
filtered through 0.45µm membrane filter. 
                 From this pipette out 5.0ml of solution and transferred into 100ml of 
volumetric flask and the volume was made up with diluent  
                 From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter  
                   Inject 20 µl of Standard solution for six times into the HPLC system and 
chromatograph. Compare the chromatograms visually and check for any interference. 
Preparation of Standard + placebo: 
                      Accurately weighed quantity of Placebo transferred into 20ml volumetric 
flask. To this accurately weighed quntatity of 20mg of Omeprazole and Cinitapride, 
about 10ml of sodium hydroxide was added and sonicated for 5 minutes to dissolve it. 
The volume was made up with diluent. The solution was filtered through 0.45µm 
membrane filter. 
                From this 5.0ml of solution was pipette out and transferred into 100ml of  
volumetric flask and the volume was made up with diluent. 
                 From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
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              Inject 50µl of Standard solution for six times into the HPLC system and 
chromatograph. 
             Compare the chromatograms visually and check for any interference. The 
solution was filtered through 0.45m membrane filter. The solution was injected and the 
reports are given in table: 10 
                                     %RSD Formula:  (σ /µ)*100 
Acceptance criteria: 
There should not be any peak in the blank and Placebo solution run at the retention time 
corresponding to Omeprazole and Cinitapride as in standard run. 
 
Chromatogram showing Specificity- Blank solution 
Fig No : 5.2.24 
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Chromatogram showing Specificity-Standard-1 solution of Omeprazole and 
Cinitapride. 
Fig No : 5.2.25 
 
Peak name RT Area 
Omeprazole 2.391 12523307 
Cinitapride 4.602 2149391 
 
Chromatogram showing Specificity- Standard-2 solution of Omeprazole and 
Cinitapride. 
Fig No : 5.2.26 
 
 
Peak name RT Area 
Omeprazole 2.389 12604652 
Cinitapride 4.604 2160105 
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Chromatogram showing Specificity-Standard-3 solution of Omeprazole and 
Cinitapride. 
Fig No : 5.2.27 
 
Peak name RT Area 
Omeprazole 2.392 12529869 
Cinitapride 4.606 2153372 
 
Chromatogram showing Specificity- Standard-4 solution of Omeprazole and 
Cinitapride. 
Fig No : 5.2.28 
  
Peak name RT Area 
Omeprazole 2.389 12553487 
Cinitapride 4.605 2153144 
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Chromatogram showing Specificity- Standard-5 solution of Omeprazole and 
Cinitapride. 
Fig No : 5.2.29 
 
Peak name RT Area 
Omeprazole 2.390 12530126 
Cinitapride 4.601 2149433 
 
Chromatogram showing Blank & Standard solution-1 overlay report of 
Omeprazole and Cinitapride. 
Fig No :5.2.30 
 
Peak name RT Area 
Omeprazole 2.391 12523307 
Cinitapride 4.602 2149391 
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Table showing results of Specificity of Omeprazole and Cinitapride. 
Table No : 11 
 
 
 
 
 
 
 
5.3.5 LINEARITY&RANGE 
LINEARITY:  Linearity is the ability of the method to obtain test results that are directly 
proportional to the analyte concentration within a given range. 
Range: Range of analytical procedure is the interval between the upper and lower 
concentration of analyte in the sample (including concentrations) for which it has been 
demonstrated that the analytical procedure has a sutable level of precision, accuracy, and 
linearity. 
Procedure: 
Preparation of Standard Stock Solution: 
                    Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed 
and transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added 
and sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution 
was filtered through 0.45µm membrane filter. 
                        From this pipette out 5.0ml of solution and transferred into 100ml of 
volumetric flask and the volume was made up with diluent (stock solution). 
Preparation of   sample solutions: 
                   From the above stock solution pipette out 2.5,3.75,5,6.25, and7.5ml 
respectively into individual 25 ml of volumetric flasks and diluted up to the mark with 
diluent to prepare  of sample solutions respectively. Mix well and filter through 0.45µm 
filter. 
Parameter Omeprazole Cinitapride 
Average area 12548288 2153089 
SD 33530.0 4369.5 
%RSD 0.35 0.26 
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Inject 50µl of blank solution and each linearity level standard solutions into the 
chromatographic system and measure the peak area. Plot a graph of peak area versus 
concentration (on X-axis concentration and on Y-axis Peak area) and calculate the 
correlation coefficient. The results are tabulated shown in Table No: 11 
 
Acceptance criteria for Range: 
 Correlation coefficient should not be less than 0.99% 
The linearity data and analytical performance parameters of are shown in table and 
calibration curve of is shown Fig No:  5.2.31 
Chromatogram  showing Linearity level-1 (50%) of Omeprazole and Cinitapride. 
Fig No : 5.2.31 
 
Chromatogram showing Linearity level-2 (75%) of Omeprazole and Cinitapride. 
Fig No: 5.2.32 
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Chromatogram showing Linearity level-3 (100%) of Omeprazole and Cinitapride. 
Fig No : 5.2.33 
 
Chromatogram showing Linearity level-4 (125%) of  Omeprazole and Cinitapride. 
Fig No : 5.2.34 
 
Chromatogram showing Linearity level-5 (150%) of Omeprazole and Cinitapride. 
Fig No : 5.2.35 
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Linearity Results (for Omeprazole): 
Table No : 12 
S. No Linearity Level Concentration Area 
1 I 5µg/ml        6175171 
2 II 7.5µg/ml      10622249 
3 III 10µg/ml      12431211 
4 IV 12.5µg/ml 
     15542577 
5 V 15µg/ml      17822063 
Correlation Coefficient 0.999 
 
Figure showing Linearity graph of Omeprazole 
Fig No : 5.2.36 
  
The correlation coefficient value was found to be 0.999 
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Linearity Results for Cinitapride: 
Table No : 13 
S. No Linearity Level Concentration Area 
1 I 3.75µg/ml 1049368 
2 II 5.62µg/ml 1818704 
3 III 7.5µg/ml 2138668 
4 IV 9.35µg/ml 
2710753 
5 V 11.25µg/ml 3168558 
Correlation Coefficient 0.999 
 
Figure :5.2.37 showing linearity graph of  Cinitapride 
 
 
The correlation coefficient value was found to be 0.999 
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5.3.6 ROBUSTNESS 
It is a measure of ability to remain unaffected by small but deliberate variations in 
method parameters and provides an indication of its reliability during normal usage. 
The robustness of an analytical method was determined by analysis of aliquots 
from homogenous lots by differing physical parameters that may differ but were still 
within the specified parameters of the assay for example change in physical parameters 
like flow rate, column temperature and mobile phase ratio. 
A ) the flow rate was varied at 0.9 to 1.1 ml/min. 
Preparation of Standard Solution : 
Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed and 
transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added and 
sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution was 
filtered through 0.45µm membrane filter. 
From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent  
From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter  
 Inject 50µl of the blank solution and the standard solution l for five times and analysed 
using varied flow rates (0.9ml, 1.1ml) along with method flow rate and 
temperature.calculate the %RSD for the area of five replicate injections. 
%RSD of  Omeprazole and Cinitapride assay under these conditions is calculated and the 
results are shown in below. 
PROCEDURE 
a)The flow rate was varied at ±0.1 ml/min. 
Standard solution 70 µg/ml was prepared and analysed using the varied flow rates 
along with method flow rate and the chromatograms were recorded. The results are 
shown in table 14. 
 
Chapter: 5                                                                                                Experimental Part 
 
RVS College of Pharmaceutical Sciences, Coimbatore Page 76 
 
Flow variation-1 (1.1mL/min): 
Chromatogram showing Robustness-Flow variation (1.1ml/min) of Omeprazole  
and Cinitapride 
Fig No  : 5.2.38 
 
Robustness flow rate (0.9ml): 
Fig No :5.2.39 
 
B)  Temperature 
Preparation of Standard Solution: 
Accurately 20mg of Omeprazole and 15mg of Cinitapride  were weighed and 
transferred into 20ml volumetric flask, about 10ml of sodium hydroxide was added and 
sonicated for 5 minutes to dissolve it. The volume was made up diluent. The solution was 
filtered through 0.45µm membrane filter. 
From this pipette out 5.0ml of solution and transferred into 100ml of volumetric 
flask and the volume was made up with diluent  
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From this 5.0ml of solution was pipette out and transferred into 25ml of 
volumetric flask and the volume was made up with mobile phase. The solution was 
filtered through 0.45µm membrane filter. 
Inject 50µl of the blank solution and the standard solution of 500 µg/ml for five 
times and analysed using the varied Mobile phase composition along with the actual 
mobile phase composition in the method and calculate the %RSD for the area of five 
replicate injections. The chromatograms are as shown in Fig No:5.2. 40-5.2.43 and the 
results are tabulated shown in Table No: 14. 
                                 %RSD Formula:  (σ /µ)*100 
 
    Acceptance criteria: 
Relative standard deviation (RSD) of areas of  Omeprazole and Cinitapride from 
five standard chromatograms in all the flow rate variation and mobile phase composition 
should not be more than 2.0 %. 
 
The Temperature was varied from ±5%: 
Standard solution 10,7.5 µg/ml was prepared and analysed using the varied 
temperature  the chromatograms were recorded. 
The graphs are shown in fig 5.2.39and 5.2.40  and the results are shown in table no : 14 
 
ROBUSTNESS TEMPERATURE 450C 
Fig No :5.2.40 
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ROBUSTNESS TEMPERATURE 350C 
Fig No: 5.2.41 
 
Table showing Robustness results for change in flow rate and Temperature of 
Omeprazole and Cinitapride . 
Table No : 14 
 
 
 
 
 
Flow rate 
Inj. Sample Area P Plate count Tailing RT % 
RSD 
  1.1ml/min   Omeprazole 10160397 3811 1.50 1.922 0.925 
N   Cinitapride 1744825 6235 1.31 3.753 
0.  0.9ml/min O   Omeprazole 16773944 5275 1.21 3.181 0.873 
  Cinitapride 2895363 7434 1.31 6.098 
Temperature N 
450C 
 
     Omeprazole 12581162 4195 1.60 2.403  
0.452 N       Cinitapride 2165745 7353 1.32 4.642 
 350C 
 
O      Omeprazole 12656208 3867 1.60 2.394  
0.780 
     Cinitapride 2153255 6331 1.37 4.663 
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5.3.7  LOD & LOQ: 
    LIMIT OF DETECTION : 
    Limit of detection is the lowest concentration of the analyte that can be 
detected by injecting decreasing amount, not necessarily quantity by the method, 
under the stated experimental conditions. The minimum concentration at which the 
analyte can be detected is determined from the linearity curve by applying the 
formula. 
LOD        =    3/s/n ratio x drug concentration 
            The lowest concentration of Omeprazole that can be detected was 
determined from standard curve was 0.005µg/ml. 
          The lowest concentration of Cinitapride that can be detected was determined 
from standard curve was 0.03µg/ml. 
LIMIT OF QUANTIFICATION : 
Limit of quantitation is the lowest concentration of the analyte in a sample that 
can be estimated quantitatively by injecting decreasing amount of drug with 
acceptable precision and accuracy under the stated experimental conditions of the 
method .Limit of quantification can be obtained from linearity curve by applying 
the following formula. 
LOQ   = 10/s/n ratio x drug conc. 
The lowest concentration at which peak can be quantified is called LOQ. It was 
found to be 0.02µg/ml for Omeprazole and for Cinitapride was found to be 
1.4µg/ml. 
Table no. 15  LOD & LOQ results showing for Omeprazole and Cinitapride: 
  
               Sample                 LOD                  LOQ 
            Omeprazole                  0.005µg/ml                  0.02µg/ml 
            Cinitapride                   0.03µg/ml                   1.4µg/ml 
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Chromatogram for limit of detection : 
Figure no: 5.2.42 
 
 
Chromatogram for limit of quantification : 
Figure no: 5.2.43 
 
 
5.3.8 DEGRADATION STUDIES  : 
ACID (0.1N HCL): 
Test preparation: 
                    20 Omeprazole and Cinitapride capsules (Burpex)were weighed and the 
average weight was calculated. Accurately the sample equivalent to 20mg of Omeprazole 
& 15 mg of Cinitapride was weighed & transferred into 20ml volumetric flask then add 
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10mlof acid(0.1N HCL) ,shake the flask for 30min and sonicated for 1 hr to dissolve it 
contentand then add 10 base (0.1N NaoH). The solution was filtered through 0.45µm 
membrane filter. 
              5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
              5.0ml of stock solution was pipetted out and transferred into 25 ml of volumetric 
flask and the volume was made up with diluent. The solution was filtered through 
0.45µm membrane filter. Inject 50 µl of test solution into HPLC system. 
BASE(0.1N NaOH): 
Test preparation: 
                                           20 Omeprazole and Cinitapride capsules(Burpex) were 
weighed and the average weight was calculated. Accurately the sample equivalent to 
20mg of Omeprazole and 15 mg of Cinitapride was weighed & transferred into 20ml 
volumetric flask then add10 base (0.1N NaoH).,shake the flask for 30min and sonicated 
for 1 hr to dissolve it contentand then add10mlof acid(0.1N HCL)  . The solution was 
filtered through 0.45µm membrane filter. 
                      5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
                     5.0ml of stock solution was pipetted out and transferred into 25 ml of 
volumetric flask and the volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter. Inject 50 µl of test solution into HPLC system. 
PEROXIDE: 
Test preparation 
                         20 Omeprazole and Cinitapride capsules(Burpex) were weighed and the 
average weight was calculated. Accurately the sample equivalent to 20mg of Omeprazole 
& 15 mg of Cinitapride was weighed & transferred into 20ml volumetric flask and add 
5ml peroxide shake flask for 30 min sonicate for 1hr. The solution was filtered through 
0.45µm membrane filter. 
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             5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
              5.0ml of stock solution was pipetted out and transferred into 25 ml of volumetric 
flask and the volume was made up with diluent. The solution was filtered through 
0.45µm membrane filter. Inject 50 µl of test solution into HPLC system. 
LIGHT: 
Test preparation 
                      20 Omeprazole and Cinitapride capsules(Burpex) were weighed and the 
average weight was calculated. Accurately the sample equivalent to 20mg of Omeprazole 
and 15 mg of Cinitapride was weighed and kept under light for 3hr transferred into 20ml 
volumetric flask about 10ml of Sodium hydroxide was added and sonicated for 5 minutes 
to dissolve it content. The volume was made up with diluent. The solution was filtered 
through 0.45µm membrane filter. 
                      5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
            5.0ml of stock solution was pipetted out and transferred into 25 ml of 
volumetric flask and the volume was made up with diluent. The solution was 
filtered through 0.45µm membrane filter. Inject 50 µl of test solution into HPLC 
system. 
WATER: 
Test preparation 
                          20 Omeprazole and Cinitapride capsules(Burpex) were weighed and the 
average weight was calculated. Accurately the sample equivalent to 20mg of Omeprazole 
& 15 mg of Cinitapride was weighed & transferred into 20ml volumetric flask about 
10ml of water was added and sonicated for 1hr  to dissolve it content. The volume was 
made up with diluent. The solution was filtered through 0.45µm membrane filter. 
              5.0ml of above solution was pipetted out and transferred into 100ml of 
volumetric flask and the volume was made up with diluent. 
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             5.0ml of stock solution was pipetted out and transferred into 25 ml of volumetric 
flask and the volume was made up with diluent. The solution was filtered through 
0.45µm membrane filter. Inject 50 µl of test solution into HPLC system. 
 
Acceptance criteria: 
The net Degardation Should be between 1% to 50%. 
Assay formula: 
          AT               WS           DT    average wt of capsule 
--------------- x ---------- x --------- x  --------------------- x working standard. 
 AS             DS          WT          lable claim 
Where, 
AT = Peak Area of sample solution. 
AS = Peak Area of standard solution. 
WS = Weight of working standard taken in mg 
WT = Weight of sample taken in mg 
DS = Dilution of Standard solution 
DT = Dilution of sample solution 
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Table no.16  
Degradation studies showing for the Omeprazole and Cinitapride : 
Chromatogram showing peaks of acid solution of Omeprazole and  Cinitapride : 
Figure no: 5.2.44 
 
Chromatogram showing peaks of base solution of Omeprazole and  Cinitapride : 
Figure no: 5.2.45 
 
 
Test 
Area of 
OME 
Area of                  
CIN 
% Asaay 
of OME 
% Assay 
of CIN 
% deg of 
OME 
% deg of 
CIN 
Acid 11248673 1909516      89 89 10 11 
Base 11401894 1368322      90 63 9 37 
Peroxide 11469432 1260724      91 58 8 42 
Light 11217957 1203319      89 56 10 44 
Water 11466336 1981648      57 92 43 8 
Avg assay        89 75 16 25 
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Chromatogram showing peaks of peroxide solution of Omeprazole and Cinitapride: 
Figure no: 5.2.46   
 
Chromatogram showing peaks of light solution of Omeprazole and Cinitapride: 
Figure no: 5.2.47 
 
Chromatogram showing peaks of water solution of Omeprazole and cinitapride : 
Figure no: 5.2.48 
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                                    6.   RESULTS AND DISCUSSION 
 
In the present work a new method development and validation was carried out 
for the estimation of Omeprazole and Cinitapride by RP-HPLC technique. The 
wavelength selection was made at 215nm since all the two compounds maximum 
absorbance at 215 nm. 
 
Method development:  
                     For the method development several trials were carried out and reported. 
These leads to the optimized chromatographic conditions for the estimation of 
Omeprazole and Cinitapride in pharmaceutical dosage forms by Hypesil BDS C18   
(4.6×250mm,5µm) column eluted with mobile phase potassium dihydrogen phosphate 
buffer : acetonitrile (60:40) at a flow rate of 1 ml/ min and a detection wavelength of 
215 nm with injection volume of 50 µl at 40°C temperature afforded the best results.  
 
FIXED CHROMATOGRAPHIC CONDITION 
Table No: 17 
 
OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
Mode of separation isocratic elution 
Mobile phase Solvent-A: potassium 
dihydrogen phosphate pH-6.5 
Solvent-B: acetonitrile(60:40) 
Column Hypesil BDS C18  (4.6 x 
250mm, 5 µm ) 
Flow rate 1 mL/ min 
Detection  Wavelength 215 nm 
Injection volume 50 µl 
Column oven temperature 40°C 
Run time 6 min 
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Results of Trial-1:  
          Peak shapes are not good, so another trail is made by changing the column 
 
Results of Trial-2:  
         Peaks are merged, so another trial is made by changing the mobile phase ratio. 
 
Results of Trial-3:  
          Peak shape was good but theoretical plates are not passed, so  another trail is 
made. 
 
6.1. METHOD VALIDATION: 
                        After method development, the validation of the current method has 
been performed in accordance with USP requirements for assay determination 
(Category-I: analytical methods for quantitation of active ingredients in finished 
pharmaceutical products) which include accuracy, precision, selectivity, linearity and 
range, robustness and ruggedness. 
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Table showing Summary of results of method validation for   Omeprazole and 
Cinitapride:  
Table :18 
S.NO 
 
Parameter 
 
Limits 
Observation 
OME CIN 
1 
 
Specificity 
 
No 
interference 
No 
interference 
No 
interference 
2 
System 
precision 
Method 
precision 
 
RSD NMT     
2.0% 
0.60 
0.59 
0.68 
0.65 
3 
 
Linearity 
range 
Correlation 
coefficient 
NMT –
0.999 
 
0.999 
 
0.999 
4 
 
Accuracy 
 
% 
Recovery     
range     98 
–10 2 % 
 
99.6 
 
100.2 
5 
 
Limit of 
Detection 
Signal 
noise ratio 
should be 
more than 
3:1 
 
0.005 
µg/ml 
 
0.03 µg/ml 
   6 
 
Limit of 
Quantitation 
 
 
Signal 
noise ratio 
should be 
more than 
10:1 
 
 
0.02 µg/ml 
 
 
1.4 µg/ml 
7 
 
Similariy 
factor  
 
NMT 2 
 
0.9838 
 
0.9646 
8 
Number of 
Theoretical 
Plates 
 
NLT 2000 
 
6382 
 
4025 
9 
 
Robustness 
Change in 
flow and 
temperature 
 
 No effect 
on system 
suitability 
parameters 
No effect 
on system 
suitability 
parameters 
10 Forced 
degradation 
Well within 
the limit  
Pass  Pass  
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System suitability: From the system suitability studies it was observed that % RSD 
of retention times were found to be 0.2 (Omeprazole) & 0.3% (Cinitapride). USP 
tailing factor was found to be 1.5(Omeprazole) &1.3 (Cinitapride). Average theoretical 
plates are found to be 6365 (Omeprazole) & 3983 (Cinitapride). All the parameters 
were within the limit.  
 
Linearity: From the Linearity data it was observed that the method was showing 
linearity in the concentration range of 5-15µg/ml for Omeprazole & 3.75-11.25 µg/ml 
for Cinitapride. Correlation coefficient was found to be 0.999 for Omeprazole & 0.999 
for Cinitapride.  
 
Precision:The RSD of peak area for standard chromatograms of system precision 
were found to be 0.60% for Omeprazole & 0.68% for Cinitapride, and in method  
precision it was found to be 0.59% for  Omeprazole & 0.65% for Cinitapride. It passes 
method and system precision. 
   
 
Accuracy:  The percentage recovery of Omeprazole and Cinitapride were  99.6% and 
100.2%.The percentage recovery of the two drugs were within the limit. 
  
SPECIFICITY: The chromatograms of standard and sample are identical with nearly 
same retention time. No interference  due to placebo and sample at the retention time of 
analyte which shows that the method was specific. 
 
 
ROBUSTNESS : As the % RSD of retention time and asymmetry were within limits 
for variation (± 0.1ml)flow rate and (±50C) temperature.  
  As the % RSD of retention time and asymmetry were within limits for 
variation in flow rate (± 0.1 ml). Hence the allowable flow rate should be within 
0.9 ml to 1.1 ml and temperature should be 35-450C.  
 
        FORCE DEGRADATION STUDIES: The percentage degradation of                    
         Omeprazole and Cinitapride parameters like acid, base, peroxide, water and light  
        studies were found to be within the limits. 
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7. CONCLUSION 
 
 A new method is developed for Simultaneous Estimation of Omeprazole 
andCinitapride by RP-HPLC method. The sample preparation is simple and 
the analysis time is short. The analytical procedure is validated as per ICH 
guidelines and shown to be accurate, precise and specific.  
 
 This method represents a fast and sensitive analytical procedure for the 
simultaneous quantization of Omeprazole and Cinitapride. The method is 
amenable to the routine analysis of large numbers of samples with good 
precision and accuracy. 
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